Dec 05, 2024 8:00am EST Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
Nov 04, 2024 8:00am EST bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
Oct 21, 2024 10:45am EDT bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
Oct 18, 2024 12:45pm EDT bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
Oct 16, 2024 8:00am EDT bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
Oct 09, 2024 8:00am EDT bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
Sep 18, 2024 8:00am EDT Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
